The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 05, 2025

Filed:

Dec. 10, 2020
Applicant:

Shanghai Bocimed Pharmaceutical Co., Ltd., Shanghai, CN;

Inventors:

Shuhuan Ying, Shanghai, CN;

Hong Li, Shanghai, CN;

Zhixiang Chen, Shanghai, CN;

Tingting Wang, Shanghai, CN;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 9/00 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 47/26 (2006.01); A61K 47/44 (2017.01); A61K 47/54 (2017.01);
U.S. Cl.
CPC ...
A61K 9/1641 (2013.01); A61K 9/0019 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01); A61K 47/547 (2017.08);
Abstract

A fulvestrant pharmaceutical composition, a preparation method therefor, and an application thereof are provided. The fulvestrant pharmaceutical composition contains fulvestrant solid particles. The particle size of the fulvestrant solid particles satisfies that Dv(10) is selected from 0.400 micrometers to 6.000 micrometers, Dv(50) is selected from 0.700 micrometers to 6.000 micrometers, and Dv(90) is selected from 1.000 micrometers to 6.000 micrometers, provided that Dv(10) is not 0.400 micrometers, Dv(50) is not 0.700 micrometers, and Dv(90) is not 1.000 micrometers. The fulvestrant pharmaceutical composition has a long-acting sustained release.


Find Patent Forward Citations

Loading…